Possible Celiac Disease Nanotechnology Treatment Breakthrough Revealed
The treatment, called CNP-101/TAK-101, was developed at Northwestern University. It utilizes microscopic nanoparticles in an attempt to train the body’s immune system to tolerate gluten. Celiac is an autoimmune disorder that results in a person’s immune system being unable to tolerate the protein gluten, triggering inflammatory attacks on the digestive system when the substance is introduced. In the study, researchers formed a harmless shell-like structure around a tiny amount of gliadin, a component of gluten, and administered it to celiac patients for about a week before testing their reaction to gluten for around two weeks....